Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hitomi

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|September 9, 2000
The p38 pathway provides negative feedback for Ras proliferative signalingG Chen, M Hitomi, J Han, et al.
Molecular Biology of the Cell|November 1, 1994
Nuclear mRNA accumulation causes nucleolar fragmentation in yeast mtr2 mutantT Kadowaki, M Hitomi, S Chen, et al.
Molecular Biology of the Cell|September 1, 1995
Mutations in nucleolar proteins lead to nucleolar accumulation of polyA+ RNA in Saccharomyces cerevisiaeT Kadowaki, R Schneiter, M Hitomi, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1984
Enhancement of rectal absorption of ampicillin by sodium salicylate in rabbitsT Nishihata, T Sakakura, M Hitomi, et al.
Oncogene|September 25, 1998
p21Waf1 inhibits the activity of cyclin dependent kinase 2 by preventing its activating phosphorylationM Hitomi, J Shu, M Agarwal, et al.
Oncogene|August 6, 1999
Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pur alphaD W Stacey, M Hitomi, M Kanovsky, et al.
Molecular and Cellular Biology|September 1, 1996
A DEAD-box-family protein is required for nucleocytoplasmic transport of yeast mRNAS Liang, M Hitomi, Y H Hu, et al.
The Biochemical Journal|May 15, 1989
Rat heart fatty acid-binding protein. Evidence that supports the amino acid sequence predicted from the cDNAH Kimura, M Hitomi, S Odani, et al.
Journal of Cell Science|January 1, 1995
A yeast protein that bidirectionally affects nucleocytoplasmic transportD R Singleton, S Chen, M Hitomi, et al.
Arzneimittel-Forschung|June 1, 1972
Pharmacological study of piroheptine, a new antiparkinson drug, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidine. I. Effects on drug-induced tremor and catatonia, and on adrenergic actionsM Hitomi, N Kumadaki, T Furukawa, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|September 9, 2000
The p38 pathway provides negative feedback for Ras proliferative signalingG Chen, M Hitomi, J Han, et al.
Molecular Biology of the Cell|November 1, 1994
Nuclear mRNA accumulation causes nucleolar fragmentation in yeast mtr2 mutantT Kadowaki, M Hitomi, S Chen, et al.
Molecular Biology of the Cell|September 1, 1995
Mutations in nucleolar proteins lead to nucleolar accumulation of polyA+ RNA in Saccharomyces cerevisiaeT Kadowaki, R Schneiter, M Hitomi, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1984
Enhancement of rectal absorption of ampicillin by sodium salicylate in rabbitsT Nishihata, T Sakakura, M Hitomi, et al.
Oncogene|September 25, 1998
p21Waf1 inhibits the activity of cyclin dependent kinase 2 by preventing its activating phosphorylationM Hitomi, J Shu, M Agarwal, et al.
Oncogene|August 6, 1999
Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pur alphaD W Stacey, M Hitomi, M Kanovsky, et al.
Molecular and Cellular Biology|September 1, 1996
A DEAD-box-family protein is required for nucleocytoplasmic transport of yeast mRNAS Liang, M Hitomi, Y H Hu, et al.
The Biochemical Journal|May 15, 1989
Rat heart fatty acid-binding protein. Evidence that supports the amino acid sequence predicted from the cDNAH Kimura, M Hitomi, S Odani, et al.
Journal of Cell Science|January 1, 1995
A yeast protein that bidirectionally affects nucleocytoplasmic transportD R Singleton, S Chen, M Hitomi, et al.
Arzneimittel-Forschung|June 1, 1972
Pharmacological study of piroheptine, a new antiparkinson drug, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidine. I. Effects on drug-induced tremor and catatonia, and on adrenergic actionsM Hitomi, N Kumadaki, T Furukawa, et al.
Pageof 5